VME.F VIROMED MEDICAL NA O.N.

Healthcare Medical Devices Frankfurt Exchange
3.72 EUR
Close of Nov 12, 2026
3.64 7.85
Market cap
EUR 79.1M
P/E
-
P/B
9.06x
ROE
5.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is VME.F undervalued?

Graham number

The Graham number of VIROMED MEDICAL NA O.N. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VIROMED MEDICAL NA O.N. fundamental analysis

No fundamental analysis for VIROMED MEDICAL NA O.N. yet.

VIROMED MEDICAL NA O.N. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VIROMED MEDICAL NA O.N.

Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections. It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was f…

Full company profile